EPO – The role of patents in the pharmaceutical sector
Today senior experts from the European Patent Office (EPO) met online with representatives of the European Alliance for Responsible R&D and Affordable Medicines to discuss aspects of the patent system in the pharmaceutical sector.
The discussion highlighted the importance of transparency and dialogue with civil society, especially when it comes to innovation with the potential to save lives and improve the well-being of millions of people. Participants exchanged on questions related to the patent granting process, with a focus on health-related technologies. The EPO invited the European Alliance to contribute to the public online user consultation on the Guidelines for Examination, which runs each year from February to April. The EPO also invited the European Alliance to participate in the activities of the Observatory on Patents and Technology. Lastly, the EPO and the Alliance engaged in a brief discussion on the EPO’s co-operation activities with non-member states.
More information on the EPO website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (12 mars 2024). EPO – The role of patents in the pharmaceutical sector. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/w059





